Quazi Ibrahim Selected Research

Quazi Ibrahim Research Topics

3	Critical Illness (Critically Ill) 04/2024 - 01/2016
2	Pulmonary Embolism 04/2024 - 01/2023
2	Hemorrhage 04/2024 - 12/2014
2	COVID-19 09/2020 - 01/2020
2	Frailty 01/2016 - 02/2014
2	ST Elevation Myocardial Infarction 01/2015 - 08/2013
1	Postmenopausal Osteoporosis 01/2023
1	Hemoptysis 01/2023
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2023
1	Venous Thrombosis (Deep-Vein Thrombosis) 01/2023
1	Osteoporosis 01/2023
1	Stroke (Strokes) 01/2021
1	Respiratory Insufficiency (Respiratory Failure) 09/2020
1	Apnea 01/2020
1	Death (Near-Death Experience) 01/2020
1	Obesity 01/2019
1	Heart Failure 11/2017
1	Thromboembolism 12/2014
1	Heart Diseases (Heart Disease) 10/2012
1	Neoplasms (Cancer) 10/2012

2	fibrin fragment D (D-dimer)IBA 04/2024 - 01/2023
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2020 - 01/2020
1	4- ((1,4,8,11- tetraazacyclotetradec- 1- yl)methyl)benzoic acidIBA 04/2024
1	Pantoprazole (Protonix)FDA LinkGeneric 04/2024
1	Proton Pump InhibitorsIBA 04/2024
1	Denosumab FDA Link 01/2023
1	Oxygen (Dioxygen)IBA 09/2020
1	Thyroxine (Levothyroxine)FDA LinkGeneric 01/2020
1	nirmatrelvir and ritonavir drug combinationIBA 01/2020
1	dicarboxydine (DCD)IBA 01/2020
1	Janus Kinase InhibitorsIBA 01/2020
1	Carbon DioxideIBA 01/2020
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2020
1	molnupiravirIBA 01/2020
1	Vasopressins (Vasopressin)IBA 01/2020
1	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 01/2020
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 12/2014
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 10/2012

2	Cannula 01/2023 - 09/2020
2	Therapeutics 01/2021 - 09/2020
2	Percutaneous Coronary Intervention 01/2015 - 08/2013
1	Extracorporeal Membrane Oxygenation 01/2023
1	Induced Hypothermia 01/2020
1	Obesity Management 01/2019
1	Transitional Care 11/2017
1	Patient Readmission 01/2016
1	Critical Care (Surgical Intensive Care) 02/2014